These days, the word 'expedited' appears frequently in the reform of the insurance benefit system. The plan is to speed up the listing of necessary new drugs by linking approval, and evaluation, and shortening the listing period at each stage. This is a good intention to quickly expand drug coverage for patients who are waiting. Shortening the insurance benefit registration period for pharmaceuticals has been discussed almost every year, and in fact, the regulatory period is getting shorter and shorter. Both the HIRA and the NHIS' evaluation and negotiation phases are similar. However, it is only a deadline for pharmaceutical companies to apply and review them.

First of all, not a few pharmaceutical co